Multiple Myeloma

Multiple Myeloma News

No Bisphosphonate Superior to Another in Multiple Myeloma According to a meta-analysis conducted by the Cochrane group, there is no evidence of superiority for any specific bisphosphonate.
Medscape Medical News, May 17, 2012
Promising Results From Combo for Advanced Multiple Myeloma More than 80% of patients with advanced multiple myeloma responded to elotuzumab plus lenalidomide and low-dose dexamethasone in a phase I study.
Reuters Health Information, May 16, 2012

Blood Cancers: Lymphoma, Myeloma Preview Dr. Bruce Cheson previews studies to be presented at ASCO® 2012 that will change or confirm therapies in follicular lymphoma, Hodgkin lymphoma, myeloma, and more.
Medscape Hematology-Oncology, May 23, 2012
Another 'CLL Case' Cured Dr. Bruce Cheson discusses a patient referral that serves as a reminder that healthy persons can harbor markers of disease when no disease is present.
Medscape Hematology-Oncology, May 23, 2012

Safety and Efficacy of Bortezomib in Multiple Myeloma
Therapeutic Advances in Hematology, May 18, 2012
Primary Plasmacytoma of the Testicle
Journal of Medical Case Reports, January 8, 2012
Advances in Transplantation Strategies for Multiple Myeloma
Cancer Control: Journal of the Moffitt Cancer Center, November 8, 2011
Predicting Thalidomide Response in Multiple Myeloma Patients
Expert Review of Proteomics, September 2, 2011
The Cancer Supportive Care Model: A Paradigm Shift
Journal of Participatory Medicine, June 23, 2011